3,5-dihydroxy-2-methyl-benzoic acid methyl ester | 147214-90-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3,5-dihydroxy-2-methyl-benzoic acid methyl ester
• 英文别名: 3,5-Dihydroxy-2-methyl-benzoesaeure-methylester；methyl 3,5-dihydroxy-2-methylbenzoate
• CAS: 147214-90-2
• 化学式: C₉H₁₀O₄
• 分子量: 182.176
• InChiKey: HJYJYOPQOZANQK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  66.8
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3,5-dihydroxy-2-methyl-benzoic acid methyl ester 、 3-溴丙烯 在 盐酸 作用下， 以 N-甲基乙酰胺 、 正己烷 、 二氯甲烷 、 乙酸乙酯 、 mineral oil 为溶剂， 生成 methyl 3-allyloxy-5-hydroxy-2-methylbenzoate
  参考文献：
  名称：

  DNA gyrase inhibitors and pharmaceutical preparations therefor

  摘要：

  公式为##STR1##的双环衍生物，其中X.sup.1、X.sup.2、R.sup.1、R.sup.2、R.sup.3、R.sup.4、R.sup.5、R.sup.6、R.sup.7a、R.sup.7b和R.sup.8的定义如规范中所述。这些化合物具有抗微生物活性。

  公开号：

  US05294609A1
• 作为产物：
  描述：

  3,5-dihydroxy-2-methylbenzoic acid 在 sodium hydroxide 、 硫酸 作用下， 以 甲醇 、 乙酸乙酯 为溶剂， 生成 3,5-dihydroxy-2-methyl-benzoic acid methyl ester
  参考文献：
  名称：

  DNA gyrase inhibitors and pharmaceutical preparations therefor

  摘要：

  公式为##STR1##的双环衍生物，其中X.sup.1、X.sup.2、R.sup.1、R.sup.2、R.sup.3、R.sup.4、R.sup.5、R.sup.6、R.sup.7a、R.sup.7b和R.sup.8的定义如规范中所述。这些化合物具有抗微生物活性。

  公开号：

  US05294609A1

文献信息

• [EN] AMINO NICOTINATE DERIVATIVES AS GLUCOKINASE (GLK) MODULATORS<br/>[FR] DERIVES D'AMINONICOTINATE JOUANT LE ROLE DE MODULATEURS DE GLUCOKINASE (GLK)
  申请人：ASTRAZENECA AB

  公开号：WO2003000267A1

  公开（公告）日：2003-01-03

  The invention related to novel compounds of Formula (I) or a salt, solvate or prodrug thereof, wherein R?1?, R2, R3, n and m are as described in the specification, useful in the treatment of a (A chemical formula should be inserted here - please see paper copy enclosed) Formula (I) disease or condition mediated through glucokinase (GLK), such as type 2 diabetes. The invention also relates to methods for preparing compounds of Formula (I) and their use as medicaments in the treatment of diseases mediated by glucokinase.

  本发明涉及一种新型化合物的公式（I）或其盐，溶剂化物或前药，其中R?1？，R2，R3，n和m如规范中所述，对治疗通过葡萄糖激酶（GLK）介导的（这里应插入一种化学式-请参见随附的纸质副本）公式（I）疾病或病况有用，例如2型糖尿病。本发明还涉及制备公式（I）化合物的方法及其作为治疗由葡萄糖激酶介导的疾病的药物的用途。
• Amino nicotinate derivatives as glucokinase (GLK) modulators
  申请人：——

  公开号：US20040214868A1

  公开（公告）日：2004-10-28

  The invention related to novel compounds of Formula (I) or a salt, solvate or prodrug thereof, wherein R 1 , R 2 , R 3 , n and m are as described in the specification, useful in the treatment of a 1 disease or condition mediated through glucokinase (GLK), such as type 2 diabetes. The invention also relates to methods for preparing compounds of Formula (I) and their use as medicaments in the treatment of diseases mediated by glucokinase.

  该发明涉及式（I）的新化合物或其盐，溶剂化合物或前药，其中R1，R2，R3，n和m如规范所述，在通过葡萄糖激酶（GLK）介导的疾病或症状的治疗中有用，例如2型糖尿病。该发明还涉及制备式（I）化合物的方法，以及它们作为药物治疗由葡萄糖激酶介导的疾病的用途。
• Process for the preparation of DNA gyrase inhibitors
  申请人：Hoffmann-La Roche Inc.

  公开号：US05486466A1

  公开（公告）日：1996-01-23

  Bicyclic derivatives of the general formula ##STR1## wherein X.sup.1 is --S-- or --SO--; X.sup.2 is --CO-- or --CS--; R.sup.1 is hydrogen, halogen or lower alkyl optionally substituted by halogen or lower alkoxy; R.sup.2 and R.sup.3 are each independently hydrogen, lower alkyl, halogen, amino, lower alkylamino, di-lower alkylamino, acylamino, lower alkexy, lower alkoxymethoxy or a group OR.sup.4 ; R.sup.4 is hydrogen or an easily hydrolyzable group; R.sup.5 is hydrogen, optionally esterified carboxy or amidated (thio)carboxy, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted acyl or heterocyclyl; R.sup.6 and R.sup.7a are each independently hydrogen or lower alkyl; R.sup.7b is hydrogen, optionally substituted hydroxy, --NR--A or --N.dbd.B, in which R is hydrogen or lower alkyl, A is hydrogen, optionally substituted alkyl, lower cycloalkyl, iminoyl, (thio)acyl, esterified carboxy or amidated (thio)carboxy and B is lower alkylidene; R.sup.7a and R.sup.7b together represent oxo, lower alkoxycarbonylmethylidene or optionally substituted hydroxyimino; and R.sup.8 is hydrogen, optionally substituted alkyl, optionally esterified carboxy or amidated (thio)carboxy; provided that no more than two of R.sup.1 -R.sup.3 are nitrogen-containing groups; no more than two of R.sup.1 -R.sup.3 are oxygen containing groups and no more than two of R.sup.1 -R.sup.3 are either nitrogen containing or oxygen containing groups; and pharmaceutically acceptable salts of the compounds of formula I carrying an acidic and/or basic substituent. The products are antimicrobially active.

  通式为##STR1##的二环衍生物，其中X.sup.1为--S--或--SO--;X.sup.2为--CO--或--CS--;R.sup.1为氢、卤素或低碳基，可选择地被卤素或低烷氧基取代;R.sup.2和R.sup.3各自独立地为氢、低烷基、卤素、氨基、低烷基氨基、双低烷基氨基、酰胺基、低烷氧基、低烷氧甲氧基或OR.sup.4基；R.sup.4为氢或易水解的基团；R.sup.5为氢、可选择酯化的羧基或酰胺化的(硫)羧基、可选择地被取代的烷基、可选择地被取代的烯基、可选择地被取代的酰基或杂环基；R.sup.6和R.sup.7a各自独立地为氢或低烷基；R.sup.7b为氢、可选择地被取代的羟基、--NR--A或--N.dbd.B，其中R为氢或低烷基，A为氢、可选择地被取代的烷基、低环烷基、亚胺基、(硫)酰基、酯化的羧基或酰胺化的(硫)羧基，B为低烷基亚甲基；R.sup.7a和R.sup.7b共同表示氧、低烷氧羰基甲基或可选择地被取代的羟亚胺基；R.sup.8为氢、可选择地被取代的烷基、可选择酯化的羧基或酰胺化的(硫)羧基；前提是R.sup.1-R.sup.3中最多有两个含氮基团；R.sup.1-R.sup.3中最多有两个含氧基团；R.sup.1-R.sup.3中最多有两个含氮基团或含氧基团；以及携带酸性和/或碱性取代基的通式I化合物的药物可接受的盐。该产品具有抗微生物活性。
• HAIR DEFORMATION TREATMENT AGENT
  申请人：Kao Corporation

  公开号：EP3228300A1

  公开（公告）日：2017-10-11

  An agent for hair deforming treatment comprising the following components (A), (B) and (C) : (A) glyoxylic acid, or a hydrate or a salt thereof, (B) resorcin, and (C) water, wherein the molar ratio of the content of the component (B) to the content of the component (A), (B)/(A), is 0.2 or more and 5 or less.

  一种用于头发变形处理的药剂，由以下成分组成(A)、(B)和(C)： (A) 乙二酸，或其水合物或鹽、 (B) 间苯二酚，以及 (C) 水、 其中(B)组分含量与(A)组分含量的摩尔比(B)/(A)为 0.2 或 0.2 以上 5 或 5 以下。
• Hair cosmetic composition
  申请人：KAO CORPORATION

  公开号：US10959925B2

  公开（公告）日：2021-03-30

  The hair cosmetic composition of the present invention, which is a one-agent type or a multi-agent type hair cosmetic composition, contains, the following components (A) to (D), the component (C) content, relative to the total composition of the hair cosmetic composition, being 0.1 mass % or higher and lower than 20 mass %: (A): a compound selected from the group consisting of glyoxylic acid, a glyoxylic acid hydrate, a glyoxylate salt, and a glyoxylamide; (B): a phenolic compound having an electron-donating group on at least one m-position and having a hydrogen atom on at least one of the o-positions and the p-position, wherein the electron-donating group on the m-position may form, together with an adjacent carbon atom, a benzene ring optionally substituted with hydroxyl group(s); (C): an organic solvent having a boiling point of 100° C. or higher; and (D): water.

  本发明的头发化妆品组合物是一种单药剂型或多药剂型头发化妆品组合物，含有以下成分（A）至（D），其中成分（C）的含量相对于头发化妆品组合物的总成分而言，大于或等于 0.1 质量%，小于 20 质量%： (A): 选自乙醛酸、乙醛酸水合物、乙醛酸盐和乙醛酰胺组成的化合物； (B) 一种酚类化合物，其至少一个 m 位上有一个电子供体，至少一个 o 位和 p 位上有一个氢原子，其中 m 位上的电子供体可与相邻的碳原子一起形成一个任选被羟基取代的苯环； (C) 沸点为 100 摄氏度或更高的有机溶剂；以及 (D) 水。